EP News Bureau

In FY 2018, the company posts Rs 981 crore PAT

PAT is at Rs 1,411 crore in FY 2018

Russian Ministry of Health has approved Sava Healthcare's DPI capsules manufacturing line for respiratory therapeutic segment

To treat metastatic castration-resistant prostate cancer in combination with methylprednisolone

Organised by Clarivate Analytics, it honours India’s most disruptive innovators

If Indian pharma firms are to continue to manufacture and export internationally, then they must start taking a hard look at the…

Life sciences companies now have a new source of competitive advantage. – use digital to build direct relationships with customers…

India's Foremost Pharma & Biotech Magazine

France-based, science-driven derma company, NAOS, is present in the Indian market since November 2014, has grown considerably…

Crossborder acquisitions contributed majority of the deal value